| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/07/2008 | WO2008018890A3 Methods for fabrication of antimicrobial surfaces |
| 08/07/2008 | WO2008016897A3 Kit and methods of treatment of an intervertebral disc |
| 08/07/2008 | WO2008005427A3 Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
| 08/07/2008 | WO2007146897A8 The treatment of xerostomia |
| 08/07/2008 | WO2007134151A3 Composition and method for increasing cell permeability of a compound |
| 08/07/2008 | WO2007120457A3 Composition and method for stabilizing corneal tissue after refractive surgery |
| 08/07/2008 | WO2007092899A3 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus |
| 08/07/2008 | WO2007079052A3 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions |
| 08/07/2008 | WO2007070564A3 Methods of treating obesity using enterostatin |
| 08/07/2008 | US20080188817 Stable Liquid IL-1 Antagonist Formulations |
| 08/07/2008 | US20080188644 Polypeptide containing metal ions stimulates skeletal growth and inhibits bone resorption; nutraceutical for preventing and treating osteoporosis and rheumatoid or osteo-arthritis |
| 08/07/2008 | US20080188643 flk-1 binding protein |
| 08/07/2008 | US20080188641 Methods for detecting and inhibiting angiogenesis |
| 08/07/2008 | US20080188437 Compositions and Methods for siRNA Inhibition of Angiogenesis |
| 08/07/2008 | US20080188436 Intact Minicells as Vectors for DNA Transfer and Gene Therapy In Vitro and In Vivo |
| 08/07/2008 | US20080188432 Short nucleotide subsequences located within number 15; such as locked nucleic acids antisense oligonucleotides; biostability, cell permeability; anticancer agents |
| 08/07/2008 | US20080188430 RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA) |
| 08/07/2008 | US20080188429 Synthetic siRNA compounds and methods for the downregulation of gene expression |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080188421 Hunter-Killer Peptides and Methods of Use |
| 08/07/2008 | US20080188420 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 08/07/2008 | US20080188419 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188418 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188416 Easily alterable or removable implants; producing desired structural change; treating wrinkles, aging effects, scars; such as polymethyl methacrylate matrix material with chondroitin sulfate |
| 08/07/2008 | US20080188415 Composition of matter containing harmonized hydroxyl modified fullerene substance |
| 08/07/2008 | US20080188414 In vivo half life; reversible pegylation using such as carbamate connector; synthesis |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188412 Anticancer agent screening; contacting in vitro with BH4 domain peptide and/or mimetic to inhibit union with FK-binding protein 38; overcoming drug resistant strains |
| 08/07/2008 | US20080188411 Preventing binding of oligodendrocyte myelin glycoprotein (OMgp) to Nogo receptor (NgR); formulations containing peptide from amino acid sequence 1 thru 6 |
| 08/07/2008 | US20080188410 Apoptosis-inducing polypeptides |
| 08/07/2008 | US20080188409 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 08/07/2008 | US20080188408 Protein and Preventive/Remedy for Neurodegenerative Diseases Such as Polyglutamine Diseases by Utilizing the Same |
| 08/07/2008 | US20080188407 Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly |
| 08/07/2008 | US20080188406 Methods and reagents for treating glucose metabolic disorders |
| 08/07/2008 | US20080188405 Cancer Markers |
| 08/07/2008 | US20080188404 Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement |
| 08/07/2008 | US20080188403 Synergistic formulation containing such as vancomycin and ceftriaxone; broad spectrum gram negative and gram positive effective agents |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080188400 Methods For Treating Bleeding |
| 08/07/2008 | US20080188399 Drug-Polymer Conjugates Coupled to a Peptidic Carrier |
| 08/07/2008 | US20080188378 Novel variants of the PapM polypeptide of bacteria of the streptomyces genus |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187962 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187591 Rapidly acting dry sealant and methods for use and manufacture |
| 08/07/2008 | US20080187583 Mixing with wetting agents; compression |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187571 mixture of calcium phosphate, collagen and glass; reabsorption |
| 08/07/2008 | US20080187556 Using human rabies virus immunoglobulins; viricide against human papillomarvirus; side effect reduction; antiaging and oxidation resistance |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187543 Using antimyostatin immunoglobulin to improving tissue wound healing |
| 08/07/2008 | US20080187542 Herpesvirus entry mediator (HVEM) specific immunoglobulin for use in treatment and prevention of transplant rejection, graft-versus-host and transplant autoimmune diseases |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187536 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187530 Novel Agents and Use Thereof |
| 08/07/2008 | US20080187529 Anti-human vegf receptor flt-1 monoclonal antibody |
| 08/07/2008 | US20080187527 Novel endometriosis-associated gene |
| 08/07/2008 | US20080187525 Nutrient capsule which enhances in vivo propagation of bifidobacterium and lactobacillus probiotics |
| 08/07/2008 | US20080187522 Enhancing a population of insulin releasing cells using gfr-a1 agonists |
| 08/07/2008 | US20080187516 Acyclic oximyl hepatitis c protease inhibitors |
| 08/07/2008 | US20080187515 Use of Immunoconjugates to Enhance the Efficacy of Multi-Stage Cascade Boosting Vaccines |
| 08/07/2008 | US20080187514 Using hematopoietic stem cells to restore functional and structural integrity to damaged myocardium; tissue engineering; tissue repair; regenerative medicine |
| 08/07/2008 | US20080187513 Treatment of Solid Cancers |
| 08/07/2008 | US20080187512 Using activator which stimulates signal transducers and activators of transcription (STAT5) gene sequences as therapeutic tools in treatment of neuromuscular disorders |
| 08/07/2008 | US20080187511 Ointment for cancer treatment |
| 08/07/2008 | US20080187510 Methods for Improving Drug Disposition |
| 08/07/2008 | US20080187509 Pharmaceutical compositions for the treatment of TNF-alpha related disorders |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187491 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 08/07/2008 | US20080187490 Administering a purified polypeptide, with high affinity to the CH2-CH3 domain of an immunoglobulin molecule; inhibiting the binding of immune complexes to effector molecules |
| 08/07/2008 | DE202006020459U1 Zubereitung mit marinem Kollagen zur Proteinasehemmung Preparation with marine collagen to Proteinasehemmung |
| 08/07/2008 | DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient |
| 08/07/2008 | CA2706744A1 Anti-fungal peptides and their use |
| 08/07/2008 | CA2706738A1 Treatment of mixed pathogen infections |
| 08/07/2008 | CA2706621A1 Anti-bacterial peptides and their use |
| 08/07/2008 | CA2677177A1 Obligate heterodimer meganucleases and uses thereof |
| 08/07/2008 | CA2677007A1 Activin-actriia antagonists and uses for treating or preventing breast cancer |
| 08/07/2008 | CA2676968A1 The use of alkaline phosphatase in the treatment of reduced renal function |
| 08/07/2008 | CA2676865A1 Template - fixed peptidomimetics |
| 08/07/2008 | CA2676795A1 Skin-beautifying agent |
| 08/07/2008 | CA2676613A1 Immunophilin ligands and methods for modulating immunophilin and calcium channel activity |
| 08/07/2008 | CA2676129A1 Methods of modulating immune function |
| 08/07/2008 | CA2675639A1 Modulators of sclerostatin biniding partners for treating bone-related disorders |
| 08/07/2008 | CA2674881A1 Fviii-independent fix-mutant proteins for hemophilia a treatment |
| 08/07/2008 | CA2674721A1 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 08/06/2008 | EP1953227A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1953172A1 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1952826A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 08/06/2008 | EP1952823A1 The use of alkaline phosphatase in the treatment of reduced renal function |
| 08/06/2008 | EP1952822A1 Factor VII polypeptides with increased affinity to platelets |